Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
23.07 USD
797.25 M USD
2.10 B USD
61.15 M
About argenx SE
Sector
Industry
CEO
Tim van Hauwermeiren
Website
Headquarters
Amsterdam
Founded
2008
ISIN
NL0010832176
FIGI
BBG008F56K85
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Related stocks
Argenx (ARGX) AnalysisCompany Overview: Argenx NASDAQ:ARGX is making significant strides in the field of autoimmune treatments, especially following the FDA approval of VYVGART Hytrulo for chronic inflammatory demyelinating polyneuropathy (CIDP) on June 21st. This approval not only enhances Argenx's product portfolio b
Argenx Lead as Chugai's Muscle Disease Treatment DisappointsIn a whirlwind of market reactions, biotech stocks Argenx ( NASDAQ:ARGX ) and Immunovant ( NASDAQ:IMVT ) emerged as frontrunners on Thursday, propelled by disappointing results from Japanese rival Chugai Pharmaceutical. The contrast in fortunes underscores the high stakes and volatile nature of the
Breakout trade in ARGXArgenx is another biotech stock setting up in a textbook breakout pattern.
Shares traded up through resistance Monday morning on good volume, but the move was ultimately held back by a nasty overall market.
ARGX still held up well, and will likely continue its advance higher.
$ARGX with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $ARGX after a Positive Under reaction following its earnings release placing the stock in drift D.
ARGX Bullish Trade Setup Looking to place some longs on ARGX. Argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.n top 10: 10 8 25.0% 6 (0.35%) 6 (0.35%) 0.0%
Funds Hol
Will ARGX break out ascending channelWill Argenx be Wall streets next Biotech unicorn? I am extremely bullish!
Biotech is booming business. Monoclonal antibodies are revolutionizing pharma industry.
Again great news for Argenx.
01feb2021
launches new global offering to raise funds after 'Go' decisions for CIDP treatment trials
ARGX Buy Signal To Watch .After forming the gap at the market open , NASDAQ:ARGX has succeeded to close above the Red Line around the 206.5 .
IF it succeeds today or in an upcoming day to close with bullish strength considerably above the green line at around the 217 mark ,I think It is likely to continue up to around th
argenx Announces Positive Topline Results from Phase 3 ADAPT TriARGX: argenx SE
2020-05-26 01:00:00
argenx Announces Positive Topline Results from Phase 3 ADAPT Trial of Efgartigimod in Patients with Generalized Myasthenia Gravis
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ARGNF is featured.
Frequently Asked Questions
The current price of ARGNF is 800.00 USD — it has increased by 17.11% in the past 24 hours. Watch Argen X NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Argen X NV stocks are traded under the ticker ARGNF.
We've gathered analysts' opinions on Argen X NV future price: according to them, ARGNF price has a max estimate of 1,031.90 USD and a min estimate of 763.72 USD. Watch ARGNF chart and read a more detailed Argen X NV stock forecast: see what analysts think of Argen X NV and suggest that you do with its stocks.
ARGNF reached its all-time high on Sep 10, 2025 with the price of 800.00 USD, and its all-time low was 10.22 USD and was reached on Apr 30, 2015. View more price dynamics on ARGNF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ARGNF stock is 14.61% volatile and has beta coefficient of 0.79. Track Argen X NV stock price on the chart and check out the list of the most volatile stocks — is Argen X NV there?
Today Argen X NV has the market capitalization of 43.91 B, it has increased by 7.41% over the last week.
Yes, you can track Argen X NV financials in yearly and quarterly reports right on TradingView.
Argen X NV is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our Earnings Calendar.
ARGNF net income for the last half-year is 447.42 M USD, while the previous report showed 827.76 M USD of net income which accounts for −45.95% change. Track more Argen X NV financial stats to get the full picture.
No, ARGNF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 29, 2025, the company has 1.6 K employees. See our rating of the largest employees — is Argen X NV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Argen X NV EBITDA is 447.84 M USD, and current EBITDA margin is −2.12%. See more stats in Argen X NV financial statements.
Like other stocks, ARGNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Argen X NV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Argen X NV technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Argen X NV stock shows the strong buy signal. See more of Argen X NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.